Literature DB >> 10196473

Allelic recombination and linkage disequilibrium within Msp-1 of Plasmodium falciparum, the malignant human malaria parasite.

N Sakihama1, M Kimura, K Hirayama, T Kanda, K Na-Bangchang, S Jongwutiwes, D Conway, K Tanabe.   

Abstract

The C-terminal, cysteine-rich 19kDa domain of merozoite surface protein-1 (MSP-1) of Plasmodium falciparum is a target of the host's humoral immunity and thus a malaria vaccine candidate. Although variation in the 19kDa domain is limited among parasite isolates, tertiary structure-dependent intramolecular associations between the 19kDa domain and other parts of MSP-1 are suggested to be involved in immune evasion by allowing competitive binding of protective and non-protective antibodies directed to their epitopes, which are conformationally in close proximity but separated at the primary structure. Since allelic recombination can account for the major variability of the Msp-1 gene, we examined whether linkage disequilibrium occurs between polymorphic loci in the 5'- and the 3'-region, the latter encoding the 19kDa domain. From 184 Thai field isolates, we selected 69 isolates with a single allelic type in six variable blocks of Msp-1 as determined by PCR-based allelic typing. All the isolates showed no evidence of recombination in blocks 6 to 16, whereas recombination was apparent in blocks 2 to 6. Sequencing of the 3'-region revealed two potential recombination sites in block 17. Strong linkage disequilibrium was seen between polymorphic loci in the 5'- and 3'-regions. The strength of this disequilibrium did not correlate with distance between loci. We discuss the possible role of epistatic selection on particular association types (haplotypes) of Msp-1.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10196473     DOI: 10.1016/s0378-1119(99)00069-4

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  18 in total

1.  Evidence for intragenic recombination in Plasmodium falciparum: identification of a novel allele family in block 2 of merozoite surface protein-1: Asembo Bay Area Cohort Project XIV.

Authors:  Shannon Takala; OraLee Branch; Ananias A Escalante; Simon Kariuki; John Wootton; Altaf A Lal
Journal:  Mol Biochem Parasitol       Date:  2002 Nov-Dec       Impact factor: 1.759

2.  Genetic diversity in the Block 2 region of the merozoite surface protein 1 (MSP-1) of Plasmodium falciparum: additional complexity and selection and convergence in fragment size polymorphism.

Authors:  S L Takala; A A Escalante; O H Branch; S Kariuki; S Biswas; S C Chaiyaroj; A A Lal
Journal:  Infect Genet Evol       Date:  2006-03-06       Impact factor: 3.342

Review 3.  Population structure and recent evolution of Plasmodium falciparum.

Authors:  S M Rich; F J Ayala
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

4.  Plasmodium falciparum genotypes, low complexity of infection, and resistance to subsequent malaria in participants in the Asembo Bay Cohort Project.

Authors:  O H Branch; S Takala; S Kariuki; B L Nahlen; M Kolczak; W Hawley; A A Lal
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

5.  Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial.

Authors:  A W Stowers; V Cioce; R L Shimp; M Lawson; G Hui; O Muratova; D C Kaslow; R Robinson; C A Long; L H Miller
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

6.  Short report: rare Plasmodium falciparum merozoite surface protein 1 19-kda (msp-1(19)) haplotypes identified in Mali using high-throughput genotyping methods.

Authors:  Shannon L Takala; David L Smith; Mahamadou A Thera; Drissa Coulibaly; Ogobara K Doumbo; Christopher V Plowe
Journal:  Am J Trop Med Hyg       Date:  2007-05       Impact factor: 2.345

Review 7.  Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'.

Authors:  S L Takala; C V Plowe
Journal:  Parasite Immunol       Date:  2009-09       Impact factor: 2.280

8.  Production of high-affinity human monoclonal antibody fab fragments to the 19-kilodalton C-terminal merozoite surface protein 1 of Plasmodium falciparum.

Authors:  Xun-Jia Cheng; Hitoshi Hayasaka; Katsuomi Watanabe; Yan-Lin Tao; Jin-Ye Liu; Hideo Tsukamoto; Toshihiro Horii; Kazuyuki Tanabe; Hiroshi Tachibana
Journal:  Infect Immun       Date:  2007-04-23       Impact factor: 3.441

9.  The Plasmodium falciparum merozoite surface protein-1 19 KD antibody response in the Peruvian Amazon predominantly targets the non-allele specific, shared sites of this antigen.

Authors:  Patrick L Sutton; Eva H Clark; Claudia Silva; OraLee H Branch
Journal:  Malar J       Date:  2010-01-04       Impact factor: 2.979

10.  Shift in epitope dominance of IgM and IgG responses to Plasmodium falciparum MSP1 block 4.

Authors:  Sandra P Chang; Alexander K K Kayatani; Zilka I Terrientes; Socrates Herrera; Rose G F Leke; Diane W Taylor
Journal:  Malar J       Date:  2010-01-13       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.